RIC can improve HSCT outcomes in older AML patientsNovember 6, 2015Leukemia, Myelodysplasia, TransplantationTransplantationAML
EC expands indication for azacitidine in AMLNovember 5, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Group identifies potential target for AMLOctober 26, 2015Leukemia, Myelodysplasia, TransplantationAML
Antibody can turn AML cells against each otherOctober 21, 2015Leukemia, Myelodysplasia, TransplantationAML
Targeting a protein to improve AML treatmentOctober 15, 2015Leukemia, Myelodysplasia, TransplantationAML
CHMP endorses expanded indication for azacitidineSeptember 30, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Variations in blood cancer survival across EuropeSeptember 28, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Abs from transplanted AML patients enhance GvL effect in vitroSeptember 24, 2015Leukemia, Myelodysplasia, TransplantationTransplantationAML
Monitoring microbiome may help reduce infection in AMLSeptember 23, 2015Leukemia, Myelodysplasia, TransplantationAML
CDK inhibitor active against lymphoma tooSeptember 22, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin Lymphoma
Traffic-related pollution linked to AML, not ALL, in kidsSeptember 19, 2015Leukemia, Myelodysplasia, TransplantationPediatricsAMLALL